Skip to main content
Erschienen in: Annals of Nuclear Medicine 5/2014

01.06.2014 | Original Article

Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer

verfasst von: Sung Jun Ahn, Mi-Suk Park, Jong Doo Lee, Won Jun Kang

Erschienen in: Annals of Nuclear Medicine | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Object

The histopathological grade of differentiation is one of the significant prognostic factors in pancreatic adenocarcinoma. Especially in the patients with unresectable pancreatic cancer, it is important to obtain the prognostic information non-invasively to avoid unnecessary invasive procedure. The aim of the study was to correlate 18F-fluorodeoxyglucose (FDG) uptake with pathologic grade of pancreatic cancer, furthermore, to evaluate prognostic value of standardized uptake value (SUV).

Methods

FDG-PET scans of 102 patients with histologically proven pancreas adenocarcinoma were retrospectively reviewed. SUV of the primary tumor was calculated for quantification analysis. Pathological differentiation was graded into well-, moderately, and poorly differentiated groups. One-way analysis of variance is performed to test the correlation of the SUV and histopathologic grades. Patients were assigned into 3 categorical groups, using SUV cut-offs of 4 and 7, respectively. Survival functions of different histologic grade and assigned groups according to SUV were estimated by Kaplan–Meier estimator and compared by log-rank test. Multivariate analysis was performed using the Cox proportional hazard regression model.

Results

There was a significant correlation of SUVs and pathologic grades (F = 4.97, p < 0.01). The mean SUV of well-, moderately and poorly differentiated groups was 4.93, 6.47 and 7.29, respectively. Tumor size, AJCC stage and treatment method were significantly related to the degree of FDG uptakes. SUV also shows a significant correlation with survival (p < 0.01), with better prognosis in lower SUV group. In multivariate analysis, the treatment method was the most strongly independent predictor (p < 0.01), followed by age (p = 0.04) and tumor size (p = 0.06). In moderately differentiated group, higher SUV showed significantly worse survival (p = 0.02).

Conclusion

SUV is related with histologic grade and might be competitive predictor for patients’ survival. Specifically, the prognosis of the patients with moderately differentiated pancreas adenocarcinoma could be stratified according to SUV.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef
2.
Zurück zum Zitat Karademir S, Sökmen S, Terzi C, Sağol O, Ozer E, Astarcioğlu H, et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000;7:489–95.PubMedCrossRef Karademir S, Sökmen S, Terzi C, Sağol O, Ozer E, Astarcioğlu H, et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000;7:489–95.PubMedCrossRef
3.
Zurück zum Zitat Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med. 1999;40:1784–91.PubMed Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med. 1999;40:1784–91.PubMed
4.
Zurück zum Zitat Franke C, Klapdor R, Meyerhoff K, Schauman M. 18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res. 1999;19:2437–42.PubMed Franke C, Klapdor R, Meyerhoff K, Schauman M. 18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res. 1999;19:2437–42.PubMed
5.
Zurück zum Zitat Adsay NV, Basturk O, Cheng JD, Andea AA. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Semin Radiat Oncol. 2005;15:254–64.PubMedCrossRef Adsay NV, Basturk O, Cheng JD, Andea AA. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Semin Radiat Oncol. 2005;15:254–64.PubMedCrossRef
6.
Zurück zum Zitat Alexander D, Jhala N, Chatla C, Steinhauer J, Funkhouser E, Coffey CS, et al. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer. 2005;103:2163–70.PubMedCentralPubMedCrossRef Alexander D, Jhala N, Chatla C, Steinhauer J, Funkhouser E, Coffey CS, et al. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer. 2005;103:2163–70.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg. 2006;131:1014–20.PubMedCrossRef Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg. 2006;131:1014–20.PubMedCrossRef
8.
Zurück zum Zitat Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279–87.PubMed Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279–87.PubMed
9.
Zurück zum Zitat Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, et al. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med. 1998;25:1429–34.PubMedCrossRef Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, et al. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med. 1998;25:1429–34.PubMedCrossRef
10.
Zurück zum Zitat Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM. Standard uptake value predicts survival in non-small cell lung cancer. Ann Thorac Surg. 2009;88:911–5.PubMedCrossRef Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM. Standard uptake value predicts survival in non-small cell lung cancer. Ann Thorac Surg. 2009;88:911–5.PubMedCrossRef
11.
Zurück zum Zitat Maemura K, Takao S, Shinchi H, Noma H, Mataki Y, et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg. 2006;13:435–41.PubMedCrossRef Maemura K, Takao S, Shinchi H, Noma H, Mataki Y, et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg. 2006;13:435–41.PubMedCrossRef
12.
Zurück zum Zitat Lee SM, Kim T-S, Lee JW, Kim S-K, Park S-J, et al. Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET. Clin Nucl Med. 2011;36:331–6.PubMedCrossRef Lee SM, Kim T-S, Lee JW, Kim S-K, Park S-J, et al. Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET. Clin Nucl Med. 2011;36:331–6.PubMedCrossRef
13.
Zurück zum Zitat Choi HJ, Kang CM, Lee WJ, Song SY, Cho A, et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer. Yonsei Med J. 2013;54:1377–83.PubMedCentralPubMedCrossRef Choi HJ, Kang CM, Lee WJ, Song SY, Cho A, et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer. Yonsei Med J. 2013;54:1377–83.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol. 2008;14:64–9.PubMedCentralPubMedCrossRef Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol. 2008;14:64–9.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Kloppel G, Lingenthal G, von Bulow M, Kern HF. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology. 1985;9:841–56.PubMedCrossRef Kloppel G, Lingenthal G, von Bulow M, Kern HF. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology. 1985;9:841–56.PubMedCrossRef
16.
Zurück zum Zitat Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000;191:154–61.PubMedCrossRef Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000;191:154–61.PubMedCrossRef
17.
Zurück zum Zitat Tannapfel A, Wittekind C, Hunefeld G. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis. Int J Pancreatol. 1992;12:145–52.PubMed Tannapfel A, Wittekind C, Hunefeld G. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis. Int J Pancreatol. 1992;12:145–52.PubMed
Metadaten
Titel
Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer
verfasst von
Sung Jun Ahn
Mi-Suk Park
Jong Doo Lee
Won Jun Kang
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 5/2014
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-014-0833-x

Weitere Artikel der Ausgabe 5/2014

Annals of Nuclear Medicine 5/2014 Zur Ausgabe